[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593450":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":14,"collaborators":7,"id":18,"slug":19,"hasResults":20,"nctId":21,"briefTitle":22,"officialTitle":23,"acronym":24,"eligibilityCriteria":25,"healthyVolunteers":20,"sex":26,"minAge":27,"maxAge":7,"enrollmentInfo":28,"targetDuration":31,"studyType":32,"phases":7,"briefSummary":33,"conditions":34,"keywords":37,"overallStatus":46,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":7},{"fullName":5,"class":6},"Vitaccess Ltd","INDUSTRY",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Mark JW Larkin, PhD","CONTACT","+44 1865818983","mark.larkin@vitaccess.com",{"type":15,"investigatorFullName":16,"investigatorTitle":17,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Mark Larkin","Mark JW Larkin, PhD,Vitaccess Ltd","100593450","vitaccess-real-cidp-registry-100593450",false,"NCT07006597","Vitaccess Real CIDP Registry","Vitaccess Real CIDP Registry: A Prospective International Observational Patient Registry in Chronic Inflammatory Demyelinating Polyneuropathy Linking Clinical and Patient-Reported Data","VRCIDP","Inclusion Criteria:\n\n* Adult (age ≥18 years) with a clinically confirmed diagnosis of CIDP by their treating neurologist\n* Resident in the US, UK or Germany\n* Access to a smartphone\u002Ftablet\u002Fcomputer\u002Flaptop\n* Willing and able to provide informed consent in their local language to take part in the study\n\nExclusion Criteria:\n\nNone","ALL","18 Years",{"count":29,"type":30},300,"ESTIMATED","10 Years","OBSERVATIONAL","Vitaccess Real CIDP (VRCIDP) is a patient registry designed to capture longitudinal observational data on chronic inflammatory demyelinating polyneuropathy (CIDP), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 300 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from electronic medical records (EMR). Patient reported and eCRF data will be linked via a unique ID and PIN assigned to each participant at enrolment.\n\nPatients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.",[35,36],"Chronic Inflammatory Demyelinating Polyneuropathy","CIDP",[38,39,40,41,42,43,44,45],"patient registry","longitudinal observational data","patient-reported outcomes","Nervous System Disease","Autoimmune Disease","Neurodegenerative Disease","Immune System Disease","Nervous System Diseases","NOT_YET_RECRUITING","2025-06-04",{"date":49,"type":50},"2025-06-05","ACTUAL",{"date":52,"type":30},"2025-07-31",{"date":54,"type":30},"2035-07",{"name":5,"class":6}]